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Transmissible mink encephalopathy (TME) occurs as sporadic outbreaks associated with
ingestion of feed presumably contaminated with some type of prion disease. Mink lack a species
barrier to primary oral challenge with bovine spongiform encephalopathy, whereas they have a
barrier to such challenge with scrapie. We investigated whether mink have a species barrier to
chronic wasting disease (CWD) by performing primary intracerebral (IC) and primary oral
challenge with CWD-positive elk brain. Primary IC challenge resulted in clinical disease in two of
eight mink at 31–33 months incubation. Affected mink had spongiform vacuolation and
astrocytosis within the central nervous system and immunoreactivity to disease-associated prion
protein (PrP
d) in brain, retina and lymph node. CWD IC recipients had significantly lower brain
vacuolation and PrP
d deposition scores, significantly lower cerebrocortical astrocyte counts and
significantly higher hippocampal astrocyte counts than TME IC recipients. Primary oral challenge
with CWD-positive elk brain (n522) or with CWD-negative elk brain given IC (n57) or orally
(n523) did not result in clinical or microscopic abnormalities during 42 months observation.
Novel prion gene polymorphisms were identified at codon 27 (arginine/tryptophan) and codon
232 (arginine/lysine). This study shows that, whilst CWD can cause disease when given IC to
mink, the lesions are not characteristic of TME, transmission is inefficient compared with TME and
oral challenge does not result in disease. The demonstration of a species barrier in cervid-to-
mustelid prion transmission indicates that mink are unlikely to be involved in natural CWD
transmission.
INTRODUCTION
Transmissible mink encephalopathy (TME) is an uncom-
mon form of prion disease that has occurred in sporadic
outbreaks on commercial mink farms in North America,
Finland, Germany and Russia (Marsh & Hadlow, 1992).
Brains from affected mink have hallmark lesions of
transmissible spongiform encephalopathy (TSE), including
spongiform vacuolation and astrocytosis that are pro-
nounced throughout the telencephalon, diencephalon and
mesencephalon (Hadlow & Karstad, 1968; Hartsough &
Burger, 1965). Investigation of TME outbreaks implicated
ingestion of ruminant tissue contaminated with some type
of prion as the source of disease (Hartsough & Burger,
1965). However, the ruminant species from which the
infected tissue originated is controversial (reviewed by
Marsh & Bessen, 1993; Marsh & Hadlow, 1992), creating
uncertainty about what role mink may have in natural
transmission of prion diseases.
Species barriers in ruminant-to-mink prion transmission
have been evaluated experimentally [for the purposes of
this report, defined as inefficient primary intracerebral (IC)
transmission and lack of primary oral transmission].
Primary IC or primary oral challenge with BSE readily
causes a TSE in mink, indicating a lack of species barrier
between cattle and mink (Robinson et al., 1994).
Conversely, a species barrier exists between sheep and
mink, as primary oral challenge with scrapie has not
produced disease (Marsh & Hanson, 1979; Marsh et al.,
1991); disease occurs only after IC administration (Hanson
et al., 1971; Marsh & Hanson, 1979). Whilst lesions in the
Journal of General Virology (2008), 89, 1086–1096 DOI 10.1099/vir.0.83422-0
1086 0008-3422 Printed in Great Britaintelencephalon, diencephalon and mesencephalon of mink
challenged IC with TME, BSE or scrapie are similar to
those seen in natural TME (Eckroade et al., 1979; Hadlow
& Karstad, 1968; Hanson et al., 1971; Hartsough & Burger,
1965; Marsh & Hadlow, 1992; Marsh & Hanson, 1979;
Robinson et al., 1994), caudal brainstem lesions indicate
that differences exist among ruminant source species, as
these lesions are consistently found in experimental TME
or BSE (Eckroade et al., 1979; Robinson et al., 1994), but
are often absent with scrapie challenge (Hanson et al.,
1971).
Chronic wasting disease (CWD) is a third ruminant TSE
that may be transmissible to mink; however, species-barrier
characteristics are uncertain as, to our knowledge, data on
primary IC challenge have not been published (Williams,
2005) and oral passage has never been performed. A species
barrier has been demonstrated in CWD transmission to
ferrets, another mustelid carnivore similar to mink but
without a history of natural TSE. Primary IC challenge of
ferrets causes disease (Bartz et al., 1998), but primary oral
challenge does not; rather, CWD material must undergo
serial IC passage in ferrets before it will cause orally
mediated disease (Perrott et al., 2004; Sigurdson et al.,
2003). Mink and ferrets differ in susceptibility to
experimental TME, as the IC incubation period in ferrets
is eight times longer than that in mink (Bartz et al., 1994).
Whether mink and ferrets also have differential suscept-
ibility to CWD is undetermined.
We initiated this study of experimental prion transmission
from cervids to mink to gain insight into whether
mustelids could be involved in natural CWD transmission.
The first cases of CWD date back to at least 1967 in
Colorado and Wyoming, USA (Spraker et al., 1997;
Williams & Young, 1980); as the majority of CWD
surveillance programmes have been initiated in the past
10 years, CWD may have previously gone undetected in
North American wildlife. CWD also occurs in many other
areas of North America, including Wisconsin and
Minnesota, USA, and Ontario, Canada (Williams, 2005).
From 1947 to 1985, cases of TME were documented in the
USA and Canada, including Wisconsin, Minnesota
(Hartsough & Burger, 1965; Marsh et al., 1991) and
Ontario (Hadlow & Karstad, 1968). Thus, CWD overlaps
geographically and temporally with some cases of prion
disease in mink. Dietary practices in the mink industry may
facilitate food-borne prion transmission, as rations are
typically prepared by grinding and mixing whole animal
carcasses, which are then fed in their entirety. If deer or elk
tissue, such as from hunting or roadkills, were included
inadvertently in mink rations, then it might be a source of
TSE in mink unbeknown to ranchers, producers or
scientific investigators. If orally administered CWD was
to cause disease in mink, then mink could serve as a disease
reservoir in the wild, as these carrion consumers are
distributed widely throughout North America. We per-
formed an oral-transmission experiment with elk CWD to
test the hypothesis that primary oral CWD challenge causes
a prion disease in mink; we also performed primary IC
CWD challenge to compare lesions with those of
experimental TME. This study provides a context for
species barriers in the transmission of prion disease from
ruminants to carnivores.
METHODS
Animals. Sixty weanling male and female black mink (e.g. non-
Aleutian-disease phenotype; Marsh et al., 1976) were purchased from
a commercial breeder with no history of TME in the CWD-free state
of Washington, USA, and cared for under guidelines of the
Washington State University Institutional Animal Care and Use and
Institutional Biosafety committees. Animals were given a four-way
vaccine (Distox plus; Schering-Plough) for distemper virus,
Pseudomonas aeruginosa, Clostridium botulinum and parvoviral
enteritis, and dewormed with ivermectin (Merck). The breeder used
a fish- and poultry-based wet feed and kits were adapted to a pelleted
ration free of ruminant protein fed ad libitum (MSC). Animals were
housed individually in stainless-steel wire cages with dedicated nest
boxes, located in a secure animal biosafety level 2 facility.
Preparation of inocula. Inocula were prepared from elk brain
stored at 220 uC. CWD-positive brains came from elk with naturally
occurring CWD in Rocky Mountain National Park, Colorado, USA,
and CWD-negative brain came from a normal elk in a closed, CWD-
free herd. Half brains (including brainstem, cerebellum and
cerebrum) were homogenized in sterile, disposable tissue grinders
(VWR International) and diluted in sterile saline to a final
concentration of 40% (w/v) for feeding and 10% (w/v) for IC
injection (Sigurdson et al., 1999). Bacterial contamination was
assessed on 10% sheep blood agar, and all samples underwent a
three-phase water bath heat-treatment cycle of 80 uC for 15 min,
37 uC for 60 min and 80 uC for an additional 15 min (bacteria were
only found in CWD-positive and TME-positive material pretreat-
ment). Gentamicin (100 mgm l
21) was added to IC inocula. Inocula
were stored at 220 uC until use.
Inoculum characterization by Western and slot blot. Disease-
associated prion protein (PrP
d) content of elk brain samples was
confirmed by Western blot, and antigen load was determined by
semiquantitative slot blot modified from a dot-blotting procedure
(O’Rourke et al., 2003). Proteinase K (PK) digestion was performed
with PK at 50 mgm l
21 at 56 uC for 30 min, with inactivation at 90 uC
for 10 min. Brain homogenates from scrapie-infected sheep or
clinically normal elk were used as positive and negative controls,
respectively. Western blot samples were denatured, run on a 12%
BisTris gel in MOPS SDS running buffer (Invitrogen) at 200 V for
1 h, and transferred to a methanol-soaked PVDF membrane in MOPS
transfer buffer (Invitrogen) at 200 mA for 1 h. Slot-blot test samples
and a plasmid-derived recombinant PrP (rPrP) densitometric
reference standard (provided by K. O’Rourke, USDA-Agricultural
Research Service, Pullman, WA, USA) were denatured and diluted
serially 1:2. Duplicate lanes of rPrP ranging from 0.66 to 21.13 ng,
one lane of CWD-negative homogenate, and five replicate lanes of
CWD-positive material were spotted onto nitrocellulose membranes
(Sigma-Aldrich) using a slotted manifold (BioRad Laboratories).
Western and slot-blot membranes were dried, then blocked for 1 h in
Tris/casein buffer (Roche), with 0.1% Tween 20. Membrane transfer,
blocking and all subsequent steps were done at room temperature.
Membranes were probed for 1 h with 3.6 mg primary mouse mAb
F99/97.6.1 ml
21 (K. O’Rourke), which recognizes prion epitope
QYQRES (O’Rourke et al., 2000), followed by biotinylated goat anti-
mouse secondary antibody (Southern Biotech) and enhanced
chemiluminescence (Amersham Biosciences). Western and slot-blot
CWD transmission to mink
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(AlphaImager; Alpha Innotech Corporation). A slot-blot standard
curve was generated from densitometric values and known quantities
of rPrP, and compared with test-sample values to estimate PrP
d
concentration [ng (mg wet tissue)
21]. Samples from brains from study
animals with TSE underwent Western blotting and densitometric
determination of glycoform ratios, with statistical significance
(P¡0.05) determined by an unpaired t-test (GraphPad 5.0).
Experimental design and procedures for IC and oral challenge.
Male and female mink were assigned randomly to one of four primary
challenge groups: CWD-positive inocula given IC (n58) and orally
(n522), and CWD-negative inocula given IC (n57) and orally
(n523). Additional mink were challenged IC with third-passage
Stetsonville TME (Marsh et al., 1991) (n52) or normal mink brain
(n52) for comparison with CWD. Available Stetsonville TME was
used in its entirety for IC challenge. TME- and CWD-negative brain
samples were administered to control for confounding variables from
oral or IC administration of homologous or heterologous brain
tissue. IC injection was performed by using a xylazine/ketamine
general anaesthetic (Robinson et al., 1994) and standard surgical-site
preparation. The skin was incised 2–3 cm, and the calvarium was
perforated with a 5/16-inch (8 mm) carbide-tipped drill bit. Brain
homogenate [100 ml of 10% (w/v)] was injected into the left cerebral
hemisphere at a 1 cm depth. Oral-challenge groups were fed 1 ml
40% (w/v) brain homogenate mixed with 5 g canned tuna fish for 5
consecutive days and observed to verify consumption of test material
(Diringer et al., 1998; Robinson et al., 1994; Sigurdson et al., 1999).
Clinical observation and necropsy of study animals. Animals
were monitored daily for signs of neurological disease, including
ataxia, muscle tremors, head pressing, hindlimb weakness, paresis or
paralysis. Clinical illness was defined as loss of appetite, lethargy,
change in aggressive behaviour, decreased awareness of surroundings
or neurological symptoms. Animals that could not enter nest boxes or
became moribund were euthanized by intracardiac injection of
sodium pentobarbital. Necropsy was performed at 3, 4, 5, 6, 7, 11, 12,
14, 24, 27, 28, 32 and 38 months with the development of
neurological symptoms or with symptoms related to other organs
(e.g. intercurrent disease). Representative tissue samples from ileum,
caecum, colon, heart, lungs, liver, kidney, spleen, mesenteric and
retropharyngeal lymph nodes, cerebrum, brainstem and cerebellum
were collected in 10% neutral-buffered formalin and/or frozen at
280 uC.
Tissue processing and immunohistochemistry. Tissue was
formalin-fixed for at least 2 days, trimmed, treated with 96% formic
acid for 1 h, processed, paraffin-embedded, sectioned at 5 mm and
placed on glass slides for haematoxylin and eosin (H/E) staining or
immunohistochemistry (IHC). IHC was performed at 37 uC with an
automated immunostainer (Ventana Medical Systems) on samples of
brain, lymph nodes and/or spleen in a manner similar to that
described previously (Spraker et al., 2002). Slides for PrP
d IHC were
blocked with EZ Prep and Cell Conditioner as per the manufacturer’s
instructions (Ventana Medical Systems), probed with primary mouse
IgG1 mAb F99/97.6.1 (provided by K. O’Rourke, USDA-Agricultural
Research Service, Pullman, WA, USA) at 5 mgm l
21 for 30 min,
followed by biotinylated secondary goat anti-mouse IgG antibody
for 10 min, streptavidin–horseradish peroxidase for 10 min and
3-amino-9-ethylcarbazole/H2O2 chromagen (Ventana Medical
Systems). Slides for glial fibrillar acidic protein (GFAP) IHC were
blocked with a commercial antibody buffer (Ventana Medical
Systems), probed with primary rabbit polyclonal antibody
(CP040C; Biocare Medical) diluted 1:600 for 12 min, followed by a
universal secondary antibody/39,39-diaminobenzidine chromagen kit
(Ultraview DAB; Ventana Medical Systems) for 8 min. Positive-
control tissues for IHC included brain or lymph node from
TSE-infected elk, deer, sheep or mink. Negative-control tissues
included tissue from uninoculated, TME-negative or CWD-negative
recipient mink. Additional negative antibody controls included
omission of primary antibodies or substitution with unrelated mouse
or rabbit primary antibodies (Ventana Medical Systems).
Tissue examination and definition of disease. Light microscopic
examination of tissue sections was performed blindly on brain
ipsilateral and contralateral to the injection site for vacuolation, PrP
d
deposition and astrocytosis. Brain and other collected tissues were
examined for intercurrent disease. Diagnosis of clinical TSE was based
on neurological signs, and disease was confirmed by detection of
spongiform vacuolation and PrP
d immunoreactivity within the brain.
Brains from asymptomatic animals were examined by PrP
d and GFAP
IHC to rule out subclinical disease. Vacuolation and PrP
d IHC
scoring was performed on five 12006800 mm fields selected
randomly from within the anatomical area of interest. Vacuolation
scores were 0 (within normal limits), 1 (vacuoles confined to white
matter), 2 (slight vacuolation in grey matter), 3 (moderate
vacuolation in grey matter with or without vacuolation in neurons),
4 (pronounced vacuolation in grey matter with or without
vacuolation in neurons) and 5 (pronounced vacuolation in grey
matter and visibly within neuronal perikaryon) [modified from Bruce
et al. (2004)]. PrP
d scores were 0 (no signal detected or background
only), 1 (slight signal intensity), 2 (moderate signal intensity) and 3
(pronounced signal intensity). PrP
d IHC was performed on lymph
nodes to determine lymphoreticular distribution. Astrocytes in GFAP
IHC sections were counted manually on five randomly selected grey-
matter fields within areas of the cerebral cortex, hippocampus and
thalamus that corresponded to areas of most severe vacuolation in
TME-positive IC recipients, using a 2006250 mm grid overlay on
commercial imaging software (Nikon Elements BR). Statistical
significance (P¡0.05) of scores and counts between treatment groups
was determined by using a Mann–Whitney test (GraphPad 5.0).
Assessment of mink PRNP genotypes. Frozen pieces of brain or
spleen were homogenized in DNA lysis buffer (100 mM NaCl,
10 mM Tris/HCl, 25 mM EDTA, 0.5% SDS) with PK (Sigma-
Aldrich), incubated overnight at 55 uC and phenol/chloroform-
extracted (Sambrook et al., 1989). PCR amplification was performed
by using primers 59-TGTTTGCAGATAAGCCATCATG-39 and 59-
ATTTCCCAGGGCCATCAG-39, yielding a 780 bp amplicon.
Sequencing was performed with primers 59-GCCATCATGGTGA-
AAAGCCAC-39,5 9-TCATCCCACTATCAGGAGAATGAGC-39 and
59-CATGATCTTCATGTCGGTCTC-39 on automated equipment
(Applied Biosystems) and analysed with commercial software
(Vector NTI; Invitrogen). Nucleotide polymorphisms were compared
with IHC findings to determine whether they were associated with
disease. Comparative amino acid alignments were performed by using
a public access program (CLUSTAL_W; http://bips.u-strasbg.fr/fr/
Documentation/ClustalW/).
RESULTS
Characterization of inocula
We characterized elk-brain samples to determine suitability
for challenge by assessing PK resistance, quantity of PrP
d
antigen and prion genotype. PrP
d immunoreactivity in
CWD-positive elk-brain homogenates was confirmed by
Western blot of PK-digested samples (Fig. 1a). Estimated
PrP
d antigen content for pooled CWD-positive samples
was 12.69±0.21 ng (mg wet tissue)
21 (Fig. 1b). Total
administered PrP
d content was approximately 127 ng for
R. D. Harrington and others
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Brain from a CWD-negative control elk did not exhibit
immunoreactivity by Western (Fig. 1a, lane 2) or slot blot.
Tissue from CWD-positive and -negative elk had a
uniform DNA sequence, including homozygosity at codon
132, consistent with a reference elk sequence (GenBank
accession no. AF016227) (O’Rourke et al., 1999).
IC challenge
Clinical signs and general histological observation. IC
challenge was performed to demonstrate pathogenic
potential of CWD-positive brain homogenates and
compare lesions induced by CWD and TME in mink.
CWD-positive IC challenge caused neurological symptoms
in two of eight (25%) mink at 936 and 993 days [mean,
964 days (32.1 months)]. Two of two (100%) TME-
positive IC recipients developed disease at 173 and
198 days [mean, 185 days (6.2 months)]. Six other CWD-
positive IC recipients, sampled at 3, 4, 5, 6, 11 and
14 months as serial time points or due to intercurrent
disease, did not have spongiform change or PrP
d deposits
within the central nervous system or peripheral tissues.
Neurological signs in IC recipients included lethargy,
inappetence, ataxia, hindlimb weakness progressing to
posterior paresis, lateral recumbency and inability to return
to nest boxes. These signs were similar in CWD and TME
recipients, except for craniodorsal reflexion of the tail,
which was only observed in the TME cases. Prion disease in
CWD and TME IC recipients with clinical signs was
confirmed by detection of spongiform vacuolation and
PrP
d immunoreactivity. Vacuolation and PrP
d deposition
were present in the obex, pons, thalamus, hypothalamus,
hippocampus and cerebral cortex of CWD-positive and
TME-positive IC recipients; however, these lesions were
consistently and significantly more severe in TME IC
recipients (Figs 2 and 3), except for cerebellar
abnormalities, which were rare in both groups. Retinal
PrP
d deposits were present in both CWD and TME IC
recipients (Fig. 3). In CWD cases, deposits had a distinct
multifocal, coarsely globular appearance, whereas retinas of
TME recipients had a more diffuse granular, and rarely
globular, presentation. Diffuse PrP
d deposits within
germinal centres of mesenteric and retropharyngeal
lymph nodes were equivalent in CWD and TME cases
(results not shown). Neurological signs and histological
abnormalities were not present in any control animals
receiving CWD-negative IC (none of seven) or TME-
negative IC (none of two).
Vacuolation. TME IC recipients had a high density of 10–
40 mm, round, clear vacuoles within grey matter and
neurons throughout the brain, sometimes confluent and
exhibiting a lace-like appearance, particularly in the
median layer of the cerebral cortex (Fig. 2). Vacuoles in
CWD IC recipients tended to be smaller and were much
less frequent, often with only a few present in an examined
area (Fig. 2). Vacuolation scores were significantly higher
in TME IC than in CWD IC recipients, except for the
cerebellum (Fig. 4).
PrP
d IHC. Multifocal PrP
d deposits in the brain had a
coarse, globular appearance in both groups. Deposits
occurred with greater signal intensity and were more
uniform in TME cases. TME cases also had areas of diffuse
granular deposits along with globular signals (Fig. 3). PrP
d
deposition scores were significantly higher in TME IC than
in CWD IC recipients, except for the cerebellum (Fig. 4).
Astrocyte quantity. GFAP-immunostained sections of the
cerebral cortex, hippocampus and thalamus were examined
to determine whether astrocytosis differed in the brains
of TME and CWD IC recipients (Figs 5 and 6).
Cerebrocortical astrocyte numbers were significantly
higher in TME recipients than in CWD recipients
(P50.0010), whereas numbers of hippocampal astrocytes
Fig. 1. Immunoreactivity and measurement of antigen load
following PK digestion of CWD-positive and CWD-negative elk-
brain samples used for experimental challenge. (a) Western blot
using 0.5 or 1.0 mg total protein. 0, Sheep scrapie brain sample
reagent control; 1, 3, 4, CWD-positive elk; 2, CWD-negative elk.
(b) Correlation between quantity of PrP (ng) and densitometric
values, shown as the integrated density value (IDV; the sum of all
pixel values in a given point of measurement after correction of the
background). &, Recombinant PrP reference standard; #, mean
amount of PrP
d in CWD-positive elk brain estimated from density
values. r
250.9491; dashed lines, 95% confidence interval.
CWD transmission to mink
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(P50.0195). Numbers of thalamic astrocytes were
equivalent between CWD and TME recipients
(P50.2108). Astrocyte counts in the cerebral cortex,
thalamus and hippocampus were significantly higher in
TSE-positive IC recipients than in the negative controls
(P50.0451, 0.0019 and 0.0010, respectively).
Western blot migration pattern and band densitometric
ratio. Brain extracts from CWD- and TME-positive IC
recipients were analysed by PK digestion and Western
blottingto determinewhetherglycoform-migration patterns
differed between the two. Glycoform-migration patterns
were identical (Fig. 7). The densitometric ratio of band
intensity was not significantly different (results not shown).
Oral challenge
Clinical signs, vacuolation and PrP
d IHC. Mink were
challenged orally with CWD-positive brain homogenates to
test the hypothesis that primary oral CWD challenge causes
prion disease in mink. Oral recipients did not exhibit
clinical neurological symptoms, vacuolation or PrP
d
deposition in neural or lymphoid tissue during the
42 months observation. Vacuole and PrP
d deposition
scores were universally 0 for all oral recipients, including
individual animals sampled (with a corresponding positive
or negative control) at 5, 6, 7, 11, 12, 14, 24, 27, 28, 32 and
38 months post-challenge as serial time points or due to
intercurrent disease. Causes of intercurrent disease
included oral trauma, pneumonia, interstitial nephritis,
intestinal obstruction, intussusception, colitis and rectal
prolapse.
Astrocyte quantification. GFAP-immunostained sections
were examined to determine whether astrocytosis was
present as an indicator of underlying neurological damage
and subclinical disease (Fig. 6). CWD-positive per os (PO)
recipients and CWD-negative PO recipients did not have a
significant difference in astrocyte counts for the cerebral
Fig. 2. Photomicrographs illustrating vacuoles in a TME-positive IC recipient (a, b, c), and a CWD-positive IC recipient (d, e, f),
but not in a CWD-negative IC recipient (g, h, i). (a, d, g) Cerebral cortex; (b, e, h) hippocampus; (c, f, i) thalamus. H/E stain.
Bars, 100 mm.
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subclinical disease (P50.1326, 0.3499 and 0.2108,
respectively).
Prion genotype
The prion gene open reading frame was sequenced to
determine whether recipient mink had any codon changes
and whether such changes correlate with disease status.
Fifty-six samples suitable for genotyping were all homo-
zygous for methionine at codon 133, consistent with codon
132 of the elk challenge material. Previously unrecognized
genetic changes in mink were detected, including an
arginine/tryptophan polymorphism at codon 27 (from
CGG to TGG, with change at bp 79), and an arginine/
lysine polymorphism at codon 232 (from AGG to AAG,
with change at bp 695) (GenBank accession no. EF508270).
The codon 27 polymorphism, found in seven heterozygous
animals, was present in one CWD-negative IC recipient,
four CWD-positive PO recipients and two CWD-negative
PO recipients. The codon 232 polymorphism, found in
four heterozygous animals, was present in two CWD-
positive and one CWD-negative IC recipient, and one
CWD-positive PO recipient. Changes in both codons never
occurred within the same animal. Of the two CWD-
positive IC recipients with disease, one had the codon 232
change, whereas the other did not. Codon changes were
not present in TME recipients. Silent base-pair changes in
Fig. 3. Photomicrographs of PrP
d IHC in brain
and retina from TME-positive IC and CWD-
positive IC recipients. (a, c, e, g) Cerebral
cortex, hippocampus, thalamus and retina,
respectively, from TME-positive IC recipient
mink. (b, d, f, h) Cerebral cortex, hippocampus,
thalamus and retina, respectively, from CWD-
positive IC recipient mink. Bars, 100 mm.
CWD transmission to mink
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(CAT, n59) and 648 (GAA, n54); sequences were
otherwise consistent with previously published data
(Kretzschmar et al., 1992). Comparative amino acid
alignment identified 23 locations where residues differ
between cervids and mustelids (Fig. 8).
DISCUSSION
The results of this study demonstrate a species barrier in
transmission of CWD to mink. Primary oral challenge with
CWD-infected elk brain did not result in clinical or
pathological findings of TSE, indicating that natural
interspecies transmission of CWD to mink is unlikely to
occur on ranches or in wildlife. Furthermore, primary IC
challenge of mink with CWD material was considerably
less efficient than IC challenge with TME, as indicated by
the prolonged incubation time and different lesion profiles.
The lack of orally mediated disease, despite a total
cumulative dose almost 200-fold greater than that given
by the IC route, shows the influence of administration
route on TSE pathogenesis. Species barriers in prion
disease are typically defined by increased attack rate and
decreased incubation time following serial IC passage of
infectious material. However, IC injection, whilst useful for
lesion comparison between strains or in the study of
molecular pathogenesis, is an experimental technique that
does not occur in nature. In the context of natural disease
transmission from cervids to mustelids, and to carnivores
in general, primary oral transmission is the scenario of
consequence. Therefore, in this study, we defined species
Fig. 4. Scores of (a) vacuolation and (b) PrP
d IHC signal intensity
in TME-positive IC recipient (filled bars) and CWD-positive IC
recipient (empty bars), by brain region (mean±SEM). *P¡0.05.
Fig. 5. Photomicrographs of astrocytes in
cerebral cortex (a, b) and hippocampus (c,
d). Astrocytes of CWD-positive IC recipients
(a, c). Astrocytes of TME-positive IC recipients
(b, d). GFAP stain. Bars, 100 mm.
R. D. Harrington and others
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primary oral transmission.
Differences in lesion profile were demonstrated qualita-
tively by TME IC recipients having more severe spongiform
vacuolation and PrP
d deposition than CWD IC recipients.
Quantitatively, TME recipients had significantly higher
scores for both vacuolation and PrP
d deposits in all regions
of the brain except for the cerebellum. Different patterns of
retinal PrP
d IHC further delineated CWD from TME in
mink tissue, as the CWD-infected animals had a multifocal
globular signal and TME recipients had a predominantly
diffuse granular signal. Significant differences in astrocyte
quantification were also informative in both IC and PO
recipients. Astrocyte counts were significantly higher in the
hippocampus of CWD IC recipients, whereas cerebrocor-
tical counts were significantly higher in TME IC recipients.
This difference, combined with astrocyte counts that were
independent of the degree of vacuolation, shows a clearly
different host response for the two types of challenge
inoculum. In PO recipients, astrocyte counts were
evaluated as an indicator of subtle neurological change in
the central nervous system. Counts were not statistically
significantly different between CWD-positive PO and
CWD-negative PO recipients, indicating a lack of under-
lying neural damage or subclinical disease that may have
developed with continued observation. The rare occur-
rence of cerebellar lesions in both CWD and TME IC
recipients is consistent with previous investigations show-
ing minimal cerebellar involvement in mink (Hanson et al.,
1971; Marsh & Hanson, 1979; Robinson et al., 1994). The
differences in lesion profile and extended incubation time
for CWD demonstrate that CWD and TME are distinctly
different diseases in the mink host.
This study complements previous ruminant-to-carnivore
transmission investigations where CWD was administered
to ferrets. Results in the ferrets were similar to those in
mink, as primary IC administration of deer CWD caused
disease (Bartz et al., 1998), whereas primary oral challenge
did not. In ferrets, serial IC passage is required before
positive PrP
d IHC is demonstrable by oral challenge
(Perrott et al., 2004; Sigurdson et al., 2003). CWD-infected
tissue originated from elk in this study, and from mule deer
in the ferret study. It is possible that CWD of mule deer
origin may behave differently in mink tissue from that of
elk origin, a hypothesis that we are currently investigating.
Nevertheless, the cumulative findings demonstrate a
species barrier in the development of disease in mustelid
carnivores (e.g. mink and ferrets) following primary oral
challenge with CWD. By extension, one may speculate that
carnivores in general are resistant to consumption of
CWD. Humans may also be resistant to CWD; whilst non-
human primates succumb to IC CWD (Marsh et al., 2005),
epidemiological investigation has not identified a clear link
between CWD and human Creutzfeldt–Jakob disease
(CJD) (Belay et al., 2004; MaWhinney et al., 2006), and
studies in humanized transgenic mice indicate CWD
resistance (Kong et al., 2005; Tamguney et al., 2006).
Continued monitoring of human disease and additional
oral-transmission studies in animals are needed to confirm
Fig. 6. Astrocyte counts (mean±SEM) by brain region. (a)
Comparison of IC recipients. Empty bars, CWD-positive IC
recipient; filled bars, TME-positive IC recipient. (b) Comparison
of PO recipients. Empty bars, CWD-negative PO recipient; filled
bars, CWD-positive PO recipient. *P¡0.05.
Fig. 7. (a) Western blot of PK-digested brain homogenates from
positive IC recipients. Lanes: M, molecular mass marker (kDa); 1,
TME IC recipient; 2, CWD IC recipient.
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mediated CWD.
Host prion gene polymorphisms are associated with TSE
susceptibility in some species. We examined prion genetics
of both challenge material and recipient mink to identify
residues that might affect interspecies transmission. Source
and recipient animals were universally homozygous for
methionine at codon 132/133 (elk and mink, respectively).
Codon 132, the site of a methionine/leucine polymorphism
in elk (O’Rourke et al., 1999), corresponds positionally to
human codon 129, where methionine homozygosity is
associated with variant CJD (Zeidler et al., 1997). The elk
polymorphism segregates with disease phenotype in CWD,
as leucine-homozygous elk have a prolonged incubation
period and altered PrP
d migration pattern compared with
methionine homozygotes (Hamir et al., 2006a; O’Rourke et
al., 2007). Codon 96 is another site of interest, as a glycine/
serine polymorphism is associated with relative CWD
susceptibility in deer (O’Rourke et al., 2004). In this study,
elk and mink had conservation of methionine at codon 132
and glycine at codon 96, indicating that these residues were
not limiting factors in disease transmission. Of the two
CWD-positive IC recipients with disease, one was homo-
zygous for arginine at codon 232; the other was a codon
232 arginine/tryptophan heterozygote. These two animals
had similar incubation periods and lesions, thus there was
no obvious effect on disease. The codon 27 polymorphism
is intriguing, as it is near the cleavage site of the
membrane-signalling portion of the prion protein
(Prusiner, 1998). As cytosolic accumulation of prion
protein has neurotoxic effects (Ma et al., 2002), signal-
ling-sequence variation could influence disease patho-
genesis through altered prion translocation to the cell
surface. All diseased animals were homozygous at codon
27, suggesting that the polymorphism could modulate
relative susceptibility; however, the small number of
affected mink precludes determination of the true effect.
Respective differences between mink and ferrets at codons
179 (phenylalanine/lysine) and 224 (arginine/glutamine)
are associated with differential susceptibility to TME (Bartz
et al., 1994). In this study, all mink were homozygous for
phenylalanine and arginine and congruous with challenge
material; it is currently unknown whether these codon
polymorphisms were a factor in previous CWD studies in
ferrets. Overall, comparative amino acid alignment shows
23 divergent residues between cervids and mustelids that
could affect transmission. Additional genetic comparison
of cervid challenge material and recipient mustelids, such
as by in vitro conversion assays (Raymond et al., 2000; Kurt
et al., 2007), is needed to delineate further possible roles of
these divergent residues.
This and previous studies provide a relative comparison of
mustelid susceptibility to cattle, sheep or cervid prions.
Primary IC or primary oral challenge of mink with BSE
results in clinicopathological abnormalities at 12 and
15 months incubation, respectively, with lesion severity
that is independent of challenge route (Robinson et al.,
1994) and occurs close to the estimated 7–12 month oral
Fig. 8. Comparative amino acid alignment
illustrating positions of disparity between
mustelids (e.g. mink, ferrets) and cervids (e.g.
mule deer, elk), or mink and ferrets that may
affect TSE susceptibility. Methionine homo-
zygosity at codon 132/133 (elk/mink, respect-
ively) is conserved. Residues boxed with thick
lines indicate the locations of new polymorph-
isms identified within mink (codon 27 RAW
and codon 232 RAW). Residues boxed with
thin lines indicate differences between mink
and ferrets that may affect TME susceptibility.
Grey shading indicates differences between
mustelids and cervids that may affect CWD
susceptibility. The underlined residue (codon
132/133) is conserved between cervids and
mustelids and is implicated in human TSE
susceptibility.
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Conversely, primary oral challenge with scrapie has not
caused disease in mink, despite repeated attempts and
observation up to 48 months (Marsh et al., 1991; Marsh &
Hanson, 1979); similarly, in this study, primary oral
challenge with CWD did not cause disease during
42 months incubation. CWD IC challenge resulted in
minor cerebrocortical involvement, whilst the cerebral
cortex is involved more extensively with scrapie or BSE IC
challenge (Hanson et al., 1971; Marsh & Hanson, 1979;
Robinson et al., 1994). IC lesions also vary by source in the
caudal brainstem, including the dorsal motor nucleus of
the vagus nerve, as they are of lesser severity with scrapie or
CWD, whilst severity increases with TME or BSE
(Eckroade et al., 1979; Hanson et al., 1971; Hartsough &
Burger, 1965; Marsh & Hadlow, 1992; Robinson et al.,
1994). IC back-passage of TME to cattle causes disease in
14.5 months, similar to TME in mink, and lesions in cattle
are similar on both first and second passage (Hamir et al.,
2006b; Robinson et al., 1995). Thus, the overall clinico-
pathological features do not change appreciably between
mink and cattle. Cumulatively, passage of TSE between
cattle and mink occurs readily, with similar lesions and
incubation times, whereas passage of CWD or scrapie to
mink is limited by route of administration, incubation
time and appearance of lesions compared with TME. As
cattle are the only ruminant without an apparent species
barrier in prion transmission to and from mink, it raises the
possibility that, in natural settings, previously unrecognized
prion or prion-like disease in cattle may have been
responsible for some cases of spongiform encephalopathy
in mink.
In this study, we demonstrated a species barrier between
elk CWD and mink, as shown by lack of orally mediated
disease and substantive differences in lesions between
CWD and TME IC recipients. Whilst CWD appears to be
readily transmissible within cervid species, this study
provides additional evidence that cervid prions are poorly
transmissible to non-cervid hosts, and is a strong
indication that mink are unlikely to be involved in natural
transmission of CWD among wildlife.
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